THE US FDA has approved
Simponi (golimumab) for the
treatment of moderate to severe
ulcerative colitis in adult patients
who have shown inadequate
response to other treatments.The above article was sent to subscribers in Pharmacy Daily's issue from 17 May 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 May 13
OVER a quarter of a million people have sbeen vaccinated against influenza this year through community pharmacies in Queensland, reported the Pharmacy Guild of Australia.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.